Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online ...

Research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for Myriad Genetics in a note issued to investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now forecasts that ...

Myriad Genetics (MYGN) has launched a new educational website providing comprehensive information about reproductive and prenatal genetic ...

A new NHS genetic testing programme has identified hundreds of people with Jewish ancestry at increased risk of cancer ...

Discussions about ethics are important in many aspects of health care but are especially critical when the health care includes genetic testing. There are several aspects of genetic testing that ...

The short answer is yes, PCOS has a complex genetic predisposition. However, lifestyle and environmental factors also play a ...

The number of home DNA test kits offering nutrition and diet advice matched to your genes is growing. They’re based on the idea that each of us responds to foods differently, in part due to our ...

Our social interactions can help or harm our health. Insights into the biology of stress from a psycho-neuro-immunological lens offer strategies for a resilient stress response.

If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...

Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...

Genetics is the branch of science concerned with genes, heredity, and variation in living organisms. It seeks to understand the process of trait inheritance from parents to offspring, including ...